Author:
Tanabe Kenneth K.,Zahrieh David,Strand Carrie A.,Hoshida Yujin,Flotte Thomas J.,Della’Zanna Gary,Umar Asad,Chavin Kenneth D.,Cleary Sean,Kubota Naoto,Llovet Josep M.,Patel Tushar,Siegel Christopher,Limburg Paul J.
Funder
NIH
Samuel Waxman Cancer Research Foundation
Fundacion Cientifica de la Asociacion Espaoola Contra el Cancer
Reference40 articles.
1. Cancer statistics, 2021;Siegel;CA Cancer J Clin,2021
2. Molecular pathogenesis and systemic therapies for hepatocellular carcinoma;Llovet;Nat Cancer,2022
3. Risk factors, pathogenesis, and strategies for hepatocellular carcinoma prevention: emphasis on secondary prevention and its Translational challenges;Li;J Clin Med,2020
4. Cellular mechanisms of liver fibrosis;Acharya;Front Pharmacol,2021
5. Targeting oxidative stress for the treatment of liver fibrosis;Luangmonkong;Rev Physiol Biochem Pharmacol,2018